Milestone Pharmaceuticals, a Canadian company with a U.S. subsidiary in Charlotte, is back on track with a potential drug to treat rapid heart rates in certain cardiovascular disorders. The company in late March re-submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking approval of etripamil for the management of paroxysmal supraventricular tachycardia (PSVT), a type of arrhythmia or abnormal heart rhythm.  ..read more

Gene therapy legend R. Jude Samulski, Ph.D., co-founder and chief scientific officer of Asklepios BioPharmaceutical (AskBio) since the company was established in 2001, is leaving the CSO job but remaining on the company board. AskBio announced that Mansuo Shannon, Ph.D., becomes CSO effective today. Shannon joins AskBio from Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, where she also served as CSO ..read more

FUJIFILM Diosynth Biotechnologies, a global contract development and manufacturing organization (CDMO), plans to invest $1.2 billion to double the size of its manufacturing facility currently under construction in Holly Springs. When completed, the site will be the largest end-to-end cell culture CDMO facility in North America, housing state-of-the-art biopharmaceutical manufacturing equipment and technology, including two large manufacturing suites for large-scale monoclonal antibody drug substance and drug product manufacturing.  ..read more

Raleigh sustainable food startup Atlantic Fish Co has developed and tested a cultivated black sea bass prototype, the company’s latest milestone in the production of sustainable seafood made from harvested fish cells. In an announcement this week with the North Carolina Food Innovation Lab (NCFIL) in Kannapolis, Atlantic Fish said development of the sea bass represents a breakthrough in cellular agriculture. The company produces seafood by harvesting fish cells, feeding them nutrients and giving them a structure to grow on ..read more

Turning ideas into impactful solutions can be a hit-or-miss proposition. To get more agricultural technology hits, the new (N.C. PSI) Startup Program helps researchers, alumni and others translate their ideas and discoveries into viable products and services that benefit agriculture ..read more

has opened its new Innovation Hub in downtown Winston-Salem’s ..read more

Over the past four decades, the life sciences industry in North Carolina has experienced an evolution, transforming the state into a global hub for innovation, research, and development. Fostering collaboration among academia, government, and industry, North Carolina's journey in the life sciences sector has led directly to discoveries improving patient’s lives right now ..read more

SCHOTT Pharma USA, Inc., part of SHOTT Pharma AG, a global specialty glass manufacturer based in Germany, plans to invest $371 million over the next five years to build a new production facility in Wilson that would create 401 jobs and produce glass pre-fillable syringes and cartridges for biopharma companies ..read more

The North Carolina Biotechnology Center, celebrating its 40th anniversary this year, launched the biannual, statewide for 2024, following the success of the initiative in 2020 and 2022 ..read more

, a Belgian agricultural technology company with a small U.S. subsidiary in Raleigh, has formed a collaboration with (formerly Novozymes) to commercialize a biofungicide for fruit and vegetable crops worldwide ..read more